Godavari Drugs Limited (BOM:530317)
125.95
+0.95 (0.76%)
At close: Jun 17, 2026
Godavari Drugs Market Cap
Godavari Drugs has a market cap or net worth of 948.47 million as of June 17, 2026. Its market cap has increased by 28.53% in one year.
Market Cap
948.47M
Enterprise Value
1.57B
Revenue
1.07B
Ranking
n/a
PE Ratio
23.50
Stock Price
125.95
Market Cap Chart
Since April 30, 2001, Godavari Drugs's market cap has increased from 15.34M to 948.47M, an increase of 6,081.74%. That is a compound annual growth rate of 17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 948.47M | 63.93% |
| Dec 31, 2025 | 578.57M | -29.74% |
| Dec 31, 2024 | 823.46M | 21.42% |
| Dec 29, 2023 | 678.20M | -5.10% |
| Dec 30, 2022 | 714.64M | 51.48% |
| Dec 31, 2021 | 471.79M | 79.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bilcare | 1.35B |
| Concord Drugs | 1.04B |
| Pharmaids Pharmaceuticals | 1.04B |
| Denis Chem Lab | 1.01B |
| Amwill Health Care | 922.17M |
| Mercury Laboratories | 910.80M |
| Makers Laboratories | 874.14M |
| Asston Pharmaceuticals | 702.57M |